Similarly, in myeloid leukemia, shorter survival was related to OX40 expression while in patients with an early stage of “non-small cell lung carcinoma” (NSCLC), higher TIL OX40L expression had a poor prognosis [15-16]. This evidence concerns the gene TNFRSF4 and non-small cell lung carcinoma.